Levels of FoxP3 expression directly correlate with Treg suppressive capacity23; therefore, these data suggest class I HDAC inhibition impairs the suppressive nature of Tregs in ovarian cancer by altering both their frequency and canonical expression programs. This evidence concerns the gene FOXP3 and ovarian carcinoma.